Stock MARKSANS MARKSANS PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Marksans Pharma Limited Bombay S.E.

Equities

MARKSANS

INE750C01026

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-07-12 am EDT 		5-day change 1st Jan Change
189 INR -1.72% Intraday chart for Marksans Pharma Limited +0.59% +17.50%
Jul. 02 Marksans Pharma Gets UK Regulator's Nod for Two Products MT
May. 31 Transcript : Marksans Pharma Limited, Q4 2024 Earnings Call, May 31, 2024

Business Summary

Marksans Pharma Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. The Company produces goods across various therapeutic areas, such as pain management, cough and cold, cardiovascular and central nervous system, anti-diabetic, gastrointestinal, hormonal treatment, and anti-allergic, among others. The Company operates four manufacturing facilities across India, the United Kingdom and the United States. The Company manufactures oral solid tablets, soft gelatin capsules and hard capsules in Goa. It also manufactures non-sterile liquids, ointments and powder products and caters to the United Kingdom, West Africa and the Middle East, which is located in the United Kingdom. The Company has spread its facility to over 7000 square meters and manufactures tablets and capsules in the United States.

Number of employees: 852

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
14,908 100.0 % 18,521 100.0 % +24.23%

Sales per region

INR in Million2022Weight2023Weight Delta
United States & North America
41.8 %
6,351 42.6 % 7,746 41.8 % +21.97%
Europe and United Kingdom
41.4 %
6,091 40.9 % 7,676 41.4 % +26.02%
Australia and New Zealand
11.3 %
1,798 12.1 % 2,095 11.3 % +16.51%
Rest of World
5.2 %
669 4.5 % 971 5.2 % +45.10%
India
0.2 %
-- 34 0.2 % -

Managers

Managers TitleAgeSince
Mark Bosco Saldanha CEO
 Chief Executive Officer 52 92-04-15
Jitendra M. Sharma DFI
 Director of Finance/CFO 55 02-09-05
Harshavardhan Panigrahi CMP
 Compliance Officer - -
Abhinna Sundar Mohanty BRD
 Director/Board Member 70 16-07-04

Members of the board

Members of the board TitleAgeSince
Sunny Sharma BRD
 Director/Board Member 49 21-08-10
Mark Bosco Saldanha CEO
 Chief Executive Officer 52 92-04-15
Sandra Mark Saldanha BRD
 Director/Board Member 52 14-09-24
Abhinna Sundar Mohanty BRD
 Director/Board Member 70 16-07-04
Digant Mahesh Parikh BRD
 Director/Board Member 51 18-03-13
Seetharama Raju Buddharaju BRD
 Director/Board Member 71 11-10-04
Varddhman V. Jain BRD
 Director/Board Member 54 16-04-30
Shailaja Vardhan BRD
 Director/Board Member 56 23-05-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 453,163,746 253,637,273 ( 55.97 %) 0 55.97 %

Shareholders

NameEquities%Valuation
Mark Bosco Saldanha
43.80 %
198,491,553 43.80 % 378 M ₹
Orbimed Asia IV Mauritius FVCI Ltd.
10.88 %
49,324,324 10.88 % 94 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
2.047 %
9,277,057 2.047 % 18 M ₹
Old Bridge Asset Management Pvt Ltd.
0.3481 %
1,577,447 0.3481 % 3 M ₹
Government of India
0.1436 %
650,852 0.1436 % 1 M ₹
Kotak Mahindra Asset Management Co. Ltd.
0.1214 %
550,000 0.1214 % 1 M ₹
Motilal Oswal Asset Management Co. Ltd.
0.0787 %
356,745 0.0787 % 679 585 ₹
Sandra Mark Saldanha
0.0729 %
330,456 0.0729 % 629 505 ₹
Groww Asset Management Ltd.
0.000412 %
1,869 0.000412 % 3 560 ₹

Company contact information

Marksans Pharma Ltd.

Oshiwara, Andheri West Grandeur, Veera Desai Extension Road

400053, Mumbai

+91 22 4001 2000

http://www.marksanspharma.com
address Marksans Pharma Limited(MARKSANS)

Group companies

NameCategory and Sector
Time-Cap Laboratories, Inc.
Logo Time-Cap Laboratories, Inc.

Time-Cap Laboratories, Inc.

Pharmaceuticals: MajorHealth Technology

Time-Cap Laboratories, Inc. offers pharmaceutical tablets and capsules. It offers diverse formulations including analgesics, laxatives, dietary supplements, cough & cold medications, prescription drugs, and several other products. The company was founded in 1979 and is headquartered in Farmingdale, NY.

Pharmaceuticals: Major

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
189.2 INR
Average target price
215 INR
Spread / Average Target
+13.66%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+62.66% 854B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.42% 636B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.37% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.16% 324B
ABBVIE INC. Stock AbbVie Inc.
+9.87% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.66% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+4.21% 230B
NOVARTIS AG Stock Novartis AG
+17.90% 228B
AMGEN INC. Stock Amgen Inc.
+14.86% 177B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MARKSANS Stock
  4. MARKSANS Stock
  5. Company Marksans Pharma Limited